Adjuvant Gemcitabine plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase Iii Nrg Oncology/Gynecologic Oncology Group Study
                        AuthID
P-00V-T7A
                
    P-00V-T7A
 
    
                     
    
                     
                    